CD8A and hepatocellular carcinoma: As NASH is characterized by the accumulation of exhausted CD8 T cells in the liver, reactivating exhausted CD8 T cells through manipulation of cellular metabolism such as restoring glycolytic pathways (120), holds the potential to reduce their inflammatory function and enhance their anti-tumor activity in NASH-driven HCC.